Is primary surgery of breast cancer patients consistent with German guidelines? Twelve-year trend of population-based clinical cancer registry data

This population‐based analysis aimed to describe the 12‐year trend of primary surgery following the introduction of national guidelines for the management of breast cancer in Germany, thus the implementation of breast‐conserving surgery (BCS) for pT1/2‐tumours and the implementation of sentinel lymp...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of cancer care Vol. 24; no. 2; pp. 242 - 252
Main Authors Schrodi, S., Niedostatek, A., Werner, C., Tillack, A., Schubert-Fritschle, G., Engel, J.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.03.2015
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This population‐based analysis aimed to describe the 12‐year trend of primary surgery following the introduction of national guidelines for the management of breast cancer in Germany, thus the implementation of breast‐conserving surgery (BCS) for pT1/2‐tumours and the implementation of sentinel lymph node biopsy (SLNB). Cancer registry data from 72 742 breast cancer patients diagnosed between 1999 and 2010 in four different regions in Germany were used. Descriptive statistics and multivariate logistic regression analysis were conducted. Between 1999 and 2010, rates of BCS for pT1/2‐tumours rose from 60.5% to 79.9%, rates of SLNB increased rapidly from 0.4% to 79.0%. Both surgical therapies were already adherent to the respective guidelines, although some regional differences could be observed: in 1999–2003, the chance of BCS was 2.6‐fold higher [odds ratio (OR) 2.6] in the western regions than in the eastern regions, but this difference decreased over time (2004–2007 OR 1.6; 2008–2010 OR 1.2). A similar pattern was observable for SLNB: in 1999–2003, the chance of receiving SLNB was 4.4‐fold higher in the western regions, but these rates converged (2004–2007 OR 3.7; 2008–2010 OR 1.5). The further increase of BCS‐ and SLNB rates after publication of guidelines and the reduction of regional differences may also be attributable to guideline implementation.
Bibliography:German Cancer Aid (Deutsche Krebshilfe)
ark:/67375/WNG-GZFLCP1P-M
ArticleID:ECC12194
istex:2563DA1ED01F23E7683B5DAF8C1F65289A5AD4A0
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0961-5423
1365-2354
DOI:10.1111/ecc.12194